(TOP (S (NP (NNP MedChem) (NNPS Products) (NNP Inc.)) (VP (VBD said) (SBAR (S (NP (NP (DT a) (NNP U.S.) (organization (NNP District) (NNP Court))) (PP (IN in) (NP (location (NNP Boston))))) (VP (VBD ruled) (SBAR (IN that) (S (NP (NP (DT a) (NN challenge)) (PP (IN by) (NP (NNP MedChem))) (PP (TO to) (NP (NP (DT the) (NN validity)) (PP (IN of) (NP (NP (DT a) (NNP U.S.) (NN patent)) (VP (VBN held) (PP (IN by) (NP (NNP Pharmacia) (NNP Inc.))))))))) (VP (AUX was) (`` `) (`` `) (PP (IN without) (NP (NN merit)))))))))) (. .)) )
(TOP (S ('' ') ('' ') (NP (NP (NNP Pharmacia)) (, ,) (VP (VBN based) (PP (IN in) (NP (NP (location (NNP Upsala))) (, ,) (NP (location (NNP Sweden)))))) (, ,)) (VP (AUX had) (VP (VBN charged) (PP (IN in) (NP (NP (DT a) (NN lawsuit)) (PP (IN against) (NP (NNP MedChem))))) (SBAR (IN that) (S (NP (NP (NNP MedChem) (POS 's)) (NN AMVISC) (NN product) (NN line)) (VP (VBZ infringes) (PP (IN on) (NP (DT the) (NNP Pharmacia) (NN patent)))))))) (. .)) )
(TOP (S (NP (DT The) (NN patent)) (VP (AUX is) (VP (VBN related) (PP (TO to) (NP (NP (JJ hyaluronic) (NN acid)) (, ,) (NP (NP (DT a) (NN rooster-comb) (VB extract)) (VP (VBN used) (PP (IN in) (NP (NN eye) (NN surgery))))))))) (. .)) )
(TOP (S (PP (IN In) (NP (PRP$ its) (NN lawsuit))) (, ,) (NP (NNP Pharmacia)) (VP (AUX is) (VP (VBG seeking) (NP (NP (JJ unspecified) (NNS damages)) (CC and) (NP (NP (DT a) (JJ preliminary) (NN injunction)) (SBAR (S (VP (TO to) (VP (VB block) (NP (NNP MedChem)) (PP (IN from) (S (VP (VBG selling) (NP (DT the) (organization (NNP AMVISC)) (NNS products))))))))))))) (. .)) )
(TOP (S (NP (DT A) (NNP MedChem) (NN spokesman)) (VP (VBD said) (SBAR (S (NP (DT the) (NNS products)) (VP (VBP contribute) (NP (NP (NP (QP (RB about) (DT a) (JJ third))) (PP (IN of) (NP (NP (NNP MedChem) (POS 's)) (NNS sales)))) (CC and) (NP (NP (QP (percentage (CD 10) (NN %) (TO to) (CD 20) (NN %)))) (PP (IN of) (NP (PRP$ its) (NNS earnings))))))))) (. .)) )
(TOP (S (PP (IN In) (NP (NP (DT the) (NN year)) (VP (VBN ended) (NP (date (NNP Aug.) (CD 31) (, ,) (CD 1988)))))) (, ,) (NP (NNP MedChem)) (VP (VBD earned) (NP (NP (QP (money ($ $) (CD 2.9) (CD million)))) (, ,) (CC or) (NP (NP (money (CD 72) (NNS cents))) (NP (DT a) (NN share))) (, ,)) (PP (IN on) (NP (NP (NNS sales)) (PP (IN of) (NP (QP (money ($ $) (CD 17.4) (CD million)))))))) (. .)) )
(TOP (S (NP (NNP MedChem)) (VP (VBD said) (SBAR (S (NP (NP (DT the) (NN court) (POS 's)) (NN ruling)) (VP (AUX was) (VP (VBN issued) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT a) (`` `) (NP (`` `) (JJ first-phase) (NN trial) ('' ')) ('' ') (PP (IN in) (NP (DT the) (NN patent-infringement) (NNS proceedings)))) (CC and) (NP (NP (NNS concerns)) (NP (NP (RB only) (CD one)) (PP (IN of) (NP (NP (PRP$ its) (NNS defenses)) (PP (IN in) (NP (DT the) (NN case)))))))))))))))) (. .)) )
(TOP (S (NP (PRP It)) (VP (VBD said) (SBAR (S (NP (PRP it)) (VP (AUX is) (VP (VBG considering) (`` `) (NP (`` `) (NP (DT all)) (PP (IN of) (NP (NP (PRP$ its) (NNS options)) (PP (IN in) (NP (NP (NN light)) (PP (IN of) (NP (DT the) (NN decision))))) (, ,) (PP (VBG including) (NP (DT a) (JJ possible) (NN appeal))))))))))) (. .)) )
(TOP (S ('' ') ('' ') (NP (DT The) (NNS medical-products) (NN company)) (VP (VBD added) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ plans) (S (VP (TO to) (`` `) (VP (`` `) (VB assert) (NP (PRP$ its) (JJ other) (NNS defenses) (POS ')) ('' ') (PP (IN against) (NP (NP (NNP Pharmacia) (POS 's)) (NN lawsuit))) (, ,) (PP (VBG including) (NP (DT the) (NN claim) (SBAR (IN that) (S (NP (PRP it)) (VP (AUX has) (RB n't) (VP (VBD infringed) (PP (IN on) (NP (NP (NNP Pharmacia) (POS 's)) (NN patent)))))))))))))))) (. .)) )
(TOP (S (NP (NNP MedChem)) (VP (VBD said) (SBAR (IN that) (S (NP (DT the) (NN court)) (VP (VBN scheduled) (NP (DT a) (NN conference)) (PP (IN for) (NP (date (JJ next) (NNP Monday)))) (: --) (S (VP (TO to) (VP (VB set) (NP (NP (DT a) (NN date)) (PP (IN for) (NP (NP (NNS proceedings)) (PP (IN on) (NP (NP (NP (NNP Pharmacia) (POS 's)) (NN motion)) (PP (IN for) (NP (DT a) (JJ preliminary) (NN injunction))))))))))))))) (. .)) )
